Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$1.2M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 1 filing we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 7 most recent Form 4 transactions.
| Nov 13, 2025 | CLDX | Celldex Therapeutics, Inc. | MEXER◆ | 6,876 | — | — | — | Open the original filing on SEC.gov |
| Nov 13, 2025 | CLDX | Celldex Therapeutics, Inc. | SSELL | 49,298 | $24.00 | $1.2M | -70.3% | Open the original filing on SEC.gov |
| Nov 13, 2025 | CLDX | Celldex Therapeutics, Inc. | MEXER | 15,750 | $22.48 | $354.1K | +29.0% | Open the original filing on SEC.gov |
| Nov 13, 2025 | CLDX | Celldex Therapeutics, Inc. | MEXER | 26,672 | $10.38 | $276.9K | +96.3% | Open the original filing on SEC.gov |
| Nov 13, 2025 | CLDX | Celldex Therapeutics, Inc. | MEXER | 6,876 | $9.02 | $62K | +33.0% | Open the original filing on SEC.gov |